259 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author배상철-
dc.date.accessioned2018-03-20T04:07:31Z-
dc.date.available2018-03-20T04:07:31Z-
dc.date.issued2013-03-
dc.identifier.citationANNALS OF THE RHEUMATIC DISEASES, 2013, 72(3), p.437-444en_US
dc.identifier.issn0003-4967-
dc.identifier.urihttp://ard.bmj.com/content/72/3/437-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/49427-
dc.description.abstractObjectives The Xq28 region containing IRAK1 and MECP2 has been identified as a risk locus for systemic lupus erythematosus (SLE) in previous genetic association studies. However, due to the strong linkage disequilibrium between IRAK1 and MECP2, it remains unclear which gene is affected by the underlying causal variant(s) conferring risk of SLE.Methods We fine-mapped >= 136 SNPs in a similar to 227 kb region on Xq28, containing IRAK1, MECP2 and seven adjacent genes (L1CAM, AVPR2, ARHGAP4, NAA10, RENBP, HCFC1 and TMEM187), for association with SLE in 15 783 case-control subjects derived from four different ancestral groups.Results Multiple SNPs showed strong association with SLE in European Americans, Asians and Hispanics at p < 5 x 10(-8) with consistent association in subjects with African ancestry. Of these, six SNPs located in the TMEM187-IRAK1-MECP2 region captured the underlying causal variant(s) residing in a common risk haplotype shared by all four ancestral groups. Among them, rs1059702 best explained the Xq28 association signals in conditional testings and exhibited the strongest p value in transancestral meta-analysis (p(meta) = 1.3 x 10(-27), OR = 1.43), and thus was considered to be the most likely causal variant. The risk allele of rs1059702 results in the amino acid substitution S196F in IRAK1 and had previously been shown to increase NF-kappa B activity in vitro. We also found that the homozygous risk genotype of rs1059702 was associated with lower mRNA levels of MECP2, but not IRAK1, in SLE patients (p = 0.0012) and healthy controls (p = 0.0064).Conclusions These data suggest contributions of both IRAK1 and MECP2 to SLE susceptibility.en_US
dc.description.sponsorshipSupport for this work was obtained from the US National Institutes of Health grants: R01AR43814 (BPT), R01AR043274 (KLM), R01AI063274 (PMG), N01AR62277 (JBH), R3724717 (JBH), AR042460 (JBH), P01AI083194 (JBH), P20RR020143 (JBH), P01AR49084 (RPK and EEB), R01AR33062 (RPK), P30AR055385 (EEB), 5UL1RR025777 (RPK and JCE), R01AR33062 (RPK), P01AR49084 (RPK, JCE, EEB, GSA, JDR, RRG, LMB and MAP), P30048311 (EEB), K08AI083790 (TBN), LRPAI071651 (TBN), R01CA141700 (MEAR), RC1AR058621 (MEAR) and UL1RR024999 (TBN), K24AR002138 (RRG), P602AR30692 (RRG), P01AR49084 (RRG), UL1RR025741 (RRG), R01AR051545-01A2 (AMS), P30AR053483 (JAJ and JMG), P30GM103510 (JAJ), U19AI082714 (JAJ and JMG), R21AI070304 (SAB), 1U54RR23417-01 (JDR), P60AR053308 (LAC), M01RR-00079 (LAC), P60AR049459 (DLK) and UL1RR029882 (DLK). This study was also supported by a grant from Lupus Research Institute (BPT, TBN), the Merit Award from the US Department of Veterans Affairs (JBH and GSG), The Alliance for Lupus Research (KLM, TBN, LAC and COJ), the Arthritis National Research Foundation Eng Tan Scholar Award (TBN), the Arthritis Foundation (AMS and PMG), the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A111218-11-GM01; SCB) and Korean R&D Programme of MKE/KEIT (10035615; YWS). Additional funding awarded from the Swedish Research Council, Swedish Association Against Rheumatism and the King Gustaf Vth 80th Jubilee Foundation and the Fundacion Instituto de Salud Carlos III PS0900129 partially funded through European FEDER funds and the Consejeria de Salud de Andalucia PI-0012, the Wenner Gren Foundation for support (CG), the Wellcome Trust (TJV), Arthritis Research UK (TJV), CTSA Grant Number I ULI RR025014-02 (AMS) from the National Center for Research Resources, Kirkland Scholar Award (LAC), Wake Forest University Health Sciences Center for Public Health Genomics (CDL, MCC, MCM, and PSR) and the Federico Wilhelm Agricola Foundation Research grant (BAPE).en_US
dc.language.isoenen_US
dc.publisherBMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLANDen_US
dc.subjectGENOME-WIDE ASSOCIATIONen_US
dc.subjectKAPPA-B ACTIVATIONen_US
dc.subjectACETYLTRANSFERASE ARD1en_US
dc.subjectGENETIC SUSCEPTIBILITYen_US
dc.subjectBINDING-PROTEINen_US
dc.subjectIDENTIFICATIONen_US
dc.subjectHAPLOTYPEen_US
dc.subjectREPLICATIONen_US
dc.subjectVARIANTSen_US
dc.subjectINSIGHTSen_US
dc.titleFine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groupsen_US
dc.typeArticleen_US
dc.relation.no3-
dc.relation.volume72-
dc.identifier.doi10.1136/annrheumdis-2012-201851-
dc.relation.page437-444-
dc.relation.journalANNALS OF THE RHEUMATIC DISEASES-
dc.contributor.googleauthorKaufman, KM-
dc.contributor.googleauthorZhao, J-
dc.contributor.googleauthorKelly, JA-
dc.contributor.googleauthorHughes, T-
dc.contributor.googleauthorAdler, A-
dc.contributor.googleauthorSanchez, E-
dc.contributor.googleauthorOjwang, JO-
dc.contributor.googleauthorLangefeld, CD-
dc.contributor.googleauthorZiegler, JT-
dc.contributor.googleauthorBae, SC-
dc.relation.code2007200731-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidscbae-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE